Sunesis to Present at the Cowen and Company 32nd Annual Health Care Conference
29 February 2012 - 11:00PM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Daniel Swisher, Chief Executive Officer of Sunesis, will be
presenting at the Cowen and Company 32nd Annual Health Care
Conference on Tuesday, March 6, 2012 at 8:40 AM Eastern Time at the
Boston Marriott Copley Place in Boston, MA.
A live webcast of the presentation will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, vosaroxin, in multiple
indications to improve the lives of people with cancer. For
additional information on Sunesis, please visit
http://www.sunesis.com. The Sunesis Pharmaceuticals, Inc. logo is
available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8773
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals,
Inc.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals, Inc. News Articles